Compare IQV & BRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IQV | BRO |
|---|---|---|
| Founded | 1982 | 1939 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6B | 24.2B |
| IPO Year | 2013 | 1994 |
| Metric | IQV | BRO |
|---|---|---|
| Price | $168.96 | $67.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 14 |
| Target Price | ★ $227.13 | $83.86 |
| AVG Volume (30 Days) | 1.2M | ★ 3.2M |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.97% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 7.84 | 3.16 |
| Revenue | ★ $9,739,000,000.00 | $5,902,000,000.00 |
| Revenue This Year | $6.78 | $25.82 |
| Revenue Next Year | $5.88 | $6.85 |
| P/E Ratio | $22.03 | ★ $21.41 |
| Revenue Growth | ★ 41.60 | 22.83 |
| 52 Week Low | $134.65 | $63.29 |
| 52 Week High | $247.05 | $121.70 |
| Indicator | IQV | BRO |
|---|---|---|
| Relative Strength Index (RSI) | 44.69 | 49.14 |
| Support Level | $159.42 | $65.68 |
| Resistance Level | $170.89 | $69.74 |
| Average True Range (ATR) | 6.19 | 2.08 |
| MACD | 1.31 | 0.42 |
| Stochastic Oscillator | 36.04 | 71.17 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Brown & Brown Inc is a diversified insurance agency, wholesale brokerage, insurance programs, and service. The company's business is divided into two reportable segments: (i) the Retail segment, and (ii) the Specialty Distribution segment. The Retail segment provides a broad range of insurance products and services to commercial, public and quasi-public entities, and to professional and individual customers, as well as non-insurance warranty services and products through automobile and recreational vehicle dealer services businesses. The Specialty Distribution segment consists of wholesale brokerage and specialty businesses. Its geographic area is U.S, U.K and Others.